Two doctors argue for and against the policy of switching patients from expensive branded statins to lower‐cost generic formulations in order to reduce NHS prescribing costs. Copyright © 2008 Wiley Interface Ltd
CITATION STYLE
Goldsmith, D., & Duerden, M. (2008). Statins: to switch or not to switch? Prescriber, 19(7), 35–41. https://doi.org/10.1002/psb.221
Mendeley helps you to discover research relevant for your work.